Skip to main content

Carlyle Group Inc.

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 1527166 WASHINGTON, DC

Position in PHAT

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$38,849,536
-$19,162,508 QoQ
Shares Held
3,496,808
0.0% QoQ
Ownership
4.38%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PHAT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Carlyle Group Inc. holds $52,484,251 across 8 Biotechnology names. PHAT ranks #1 (74.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PHAT
Phathom Pharmaceuticals, Inc.
This page
3,496,808 $38,849,536

All Filings in PHAT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $38,849,536 3,496,808
2025-12-31 $58,012,044 3,496,808
2025-09-30 $41,157,430 3,496,808
2025-08-28 $43,220,546 3,496,808
2025-06-30 $33,534,388 3,496,808
2025-03-31 $21,924,986 3,496,808
2024-12-31 $28,394,080 3,496,808
2024-09-30 $63,222,288 3,496,808
2024-06-30 $36,017,122 3,496,808
2024-03-31 $37,136,100 3,496,808
2023-12-31 $31,925,857 3,496,808
2023-09-30 $36,261,898 3,496,808
2023-06-30 $50,074,290 3,496,808
2023-03-31 $20,956,656 2,935,106